$VISK · Viskase Holdings, Inc.
Viskase Holdings filed its Q3 FY2026 10-Q, reporting a net loss of $6.4M ($0.45/share) on revenue of $95.3M (+4.5% YoY). The quarter showed improvement over the prior-year $13.0M loss, but nine-month results remain deeply negative at a $18.3M net loss. The filing discloses a going-concern warning tied to the Senior Credit Facility's August 2027 maturity, with $135.7M in short-term debt against just $7.7M cash.
- Q3 net loss narrowed to $6.4M from $13.0M YoY; operating loss improved to $3.1M from $9.1M.
- Q3 revenue rose 4.5% to $95.3M driven by $3.0M in price/mix gains and $1.0M volume increase.
- Nine-month revenue fell 3.8% to $271.9M as North America lost $16.5M in sales from 2025 restructuring capacity constraints.
- Weighted-average shares outstanding surged to 14.3M from 5.4M YoY due to the March 2026 reverse merger with Enzon.
- Management cites 'substantial doubt' about going concern absent refinancing the Senior Credit Facility before its August 2027 maturity.
Price data unavailable.
A going-concern warning combined with a 164% surge in share count from the reverse merger and persistent operating losses makes this a high-risk micro-cap situation for any remaining equity holders.
Viskase operates in the niche non-edible casings market for processed meat packaging, with eight plants globally. The reverse merger with Enzon Pharmaceuticals in March 2026 provided $40.9M in cash and a public listing vehicle, but the combined entity remains sub-scale with negative operating margins.
Going concern: the Senior Credit Facility matures August 2027 and the company states 'substantial doubt exists' about its ability to continue without refinancing. Short-term debt stands at $135.7M against $7.7M cash. The 2025 restructuring plan caused temporary production capacity constraints that drove a $16.5M North America sales decline over nine months.